Your $500 discount expires in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Feng RenCo-CEO & CSO at Insilico Medicine LtdSpeaker
Profile
Dr. Feng Ren earned his Ph.D. in Chemistry from Harvard University in 2007 and began his career in biopharmaceutical innovation at GlaxoSmithKline (GSK), where he spent nearly a decade advancing drug discovery and development.
In 2018, Dr. Ren joined Medicilon, a global contract research organization (CRO), as Senior Vice President and Head of Drug R&D Services, overseeing operations in both the Chemistry and Biology Departments with a team of over 600 chemists and biologists.
Dr. Ren transitioned to Insilico Medicine in 2021 as Chief Scientific Officer (CSO), where he assumed responsibility for advancing internal pipelines and fostering external collaborations in drug discovery and development, and was recognized with a promotion to Co-CEO in June 2022.
Agenda Sessions
Beyond the Buzz: AI in Biotech - Transformative or Incremental?
, 13:30View Session